Meloxicam

Search with Google Search with Bing

Information
Drug Name
Meloxicam
Description
Entry(CIViC)
1
CIViC
Disease Mutation EL ET ED CS VO TR Pubmed Links
Desmoid Fibromatosis CTNNB1 p.Ser45Phe (p.S45F)
( ENST00000349496.11, ENST00000441708.2, ENST00000405570.6, ENST00000431914.6, ENST00000450969.6, ENST00000453024.6, ENST00000396183.7, ENST00000396185.8, ENST00000433400.6, ENST00000642248.1, ENST00000642315.1, ENST00000642426.1, ENST00000642836.1, ENST00000642886.1, ENST00000642986.1, ENST00000642992.1, ENST00000643031.1, ENST00000643297.1, ENST00000643541.1, ENST00000643977.1, ENST00000643992.1, ENST00000644138.1, ENST00000644524.1, ENST00000644678.1, ENST00000644867.1, ENST00000644873.1, ENST00000644906.2, ENST00000645210.1, ENST00000645276.1, ENST00000645320.1, ENST00000645493.1, ENST00000645900.1, ENST00000645982.1, ENST00000646116.1, ENST00000646174.1, ENST00000646369.1, ENST00000646381.1, ENST00000646725.1, ENST00000647264.1, ENST00000647390.1, ENST00000647413.2, ENST00000715148.1, ENST00000715149.1, ENST00000715151.1 ) CTNNB1 p.Ser45Phe (p.S45F)
( ENST00000349496.11, ENST00000396183.7, ENST00000396185.8, ENST00000405570.6, ENST00000431914.6, ENST00000433400.6, ENST00000441708.2, ENST00000450969.6, ENST00000453024.6, ENST00000642248.1, ENST00000642315.1, ENST00000642426.1, ENST00000642836.1, ENST00000642886.1, ENST00000642986.1, ENST00000642992.1, ENST00000643031.1, ENST00000643297.1, ENST00000643541.1, ENST00000643977.1, ENST00000643992.1, ENST00000644138.1, ENST00000644524.1, ENST00000644678.1, ENST00000644867.1, ENST00000644873.1, ENST00000644906.2, ENST00000645210.1, ENST00000645276.1, ENST00000645320.1, ENST00000645493.1, ENST00000645900.1, ENST00000645982.1, ENST00000646116.1, ENST00000646174.1, ENST00000646369.1, ENST00000646381.1, ENST00000646725.1, ENST00000647264.1, ENST00000647390.1, ENST00000647413.2, ENST00000715148.1, ENST00000715149.1, ENST00000715151.1 )
C Predictive Does Not Support Sensitivity/Response Somatic 2 24788118 Detail
Annotation
Description Associated Genes Associated Variants Sensitivity Supported Source Links
Of the 33 patients with desmoid fibromatosis treat... CTNNB1 CTNNB1 p.Ser45Phe (p.S45F)
( ENST00000349496.11, ENST00000441708.2, ENST00000405570.6, ENST00000431914.6, ENST00000450969.6, ENST00000453024.6, ENST00000396183.7, ENST00000396185.8, ENST00000433400.6, ENST00000642248.1, ENST00000642315.1, ENST00000642426.1, ENST00000642836.1, ENST00000642886.1, ENST00000642986.1, ENST00000642992.1, ENST00000643031.1, ENST00000643297.1, ENST00000643541.1, ENST00000643977.1, ENST00000643992.1, ENST00000644138.1, ENST00000644524.1, ENST00000644678.1, ENST00000644867.1, ENST00000644873.1, ENST00000644906.2, ENST00000645210.1, ENST00000645276.1, ENST00000645320.1, ENST00000645493.1, ENST00000645900.1, ENST00000645982.1, ENST00000646116.1, ENST00000646174.1, ENST00000646369.1, ENST00000646381.1, ENST00000646725.1, ENST00000647264.1, ENST00000647390.1, ENST00000647413.2, ENST00000715148.1, ENST00000715149.1, ENST00000715151.1 ) CTNNB1 p.Ser45Phe (p.S45F)
( ENST00000349496.11, ENST00000396183.7, ENST00000396185.8, ENST00000405570.6, ENST00000431914.6, ENST00000433400.6, ENST00000441708.2, ENST00000450969.6, ENST00000453024.6, ENST00000642248.1, ENST00000642315.1, ENST00000642426.1, ENST00000642836.1, ENST00000642886.1, ENST00000642986.1, ENST00000642992.1, ENST00000643031.1, ENST00000643297.1, ENST00000643541.1, ENST00000643977.1, ENST00000643992.1, ENST00000644138.1, ENST00000644524.1, ENST00000644678.1, ENST00000644867.1, ENST00000644873.1, ENST00000644906.2, ENST00000645210.1, ENST00000645276.1, ENST00000645320.1, ENST00000645493.1, ENST00000645900.1, ENST00000645982.1, ENST00000646116.1, ENST00000646174.1, ENST00000646369.1, ENST00000646381.1, ENST00000646725.1, ENST00000647264.1, ENST00000647390.1, ENST00000647413.2, ENST00000715148.1, ENST00000715149.1, ENST00000715151.1 )
Sensitivity false CIViC Evidence detail
NCT ID Status Phase Summary Start date Completion date
NCT00042068 Completed Phase 3 A Multi-Center Trial to Compare Three Doses of Meloxicam and Placebo in Patients With Rheumatoid Arthritis June 2002 July 2003
NCT00152919 Completed Phase 3 Mobicox: Study of Meloxicam to Reduce Prostate Swelling in Permanent Seed Prostate Brachytherapy February 2004 May 2009
NCT00601887 Completed N/A Bioequivalency Study of Meloxicam Tablets Under Fed Conditions March 2005 April 2005
NCT00618163 Completed N/A Bioequivalency Study of Meloxicam Tablets Under Fasting Conditions March 2005 April 2005
NCT00635349 Completed Phase 4 A Comparative Study of Tramadol Hydrochloride Plus Acetaminophen Tablets Maintenance Versus Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Maintenance in Participants With Knee Osteoarthritis May 2007 April 2009
NCT01147289 Completed Phase 3 Efficacy and Safety of Injectable Association of Dexamethasone, Dipyrone and Hydrocobalamin in Lumbar Sciatic Pain February 2011 April 2012
NCT01161134 Completed Phase 1 Bioequivalence Study of Meloxicam Tablets 15 mg of Dr.Reddy's Laboratories Limited Under Fasting Condition September 2004 November 2004
NCT01161147 Completed Phase 1 Bioequivalence Study of Meloxicam Tablets 15 mg of Dr.Reddy's Laboratories Limited Under Fed Condition October 2004 December 2004
NCT02184065 Completed Observational Study of Meloxicam in Mexican Patients With Rheumatic Diseases January 2004
NCT02187562 Completed Phase 1 Effect of Steady State Meloxicam on Low Dose Aspirin Induced Inhibition of Platelet Aggregation and Thromboxane Synthesis in Healthy Males and Females July 2002
NCT02229747 Completed Phase 4 Efficacy and Safety of Meloxicam Suspension Versus Diclofenac Suspension or Nimesulide Suspension in Patients With a Diagnosis of Acute, Non-bacterial Pharyngitis, Pharyngotonsillitis or Laryngitis August 2001
NCT02255045 Completed Phase 2/Phase 3 Assessment of a Vaginal Ring With Meloxicam in the Treatment of Dysmenorrhea June 27, 2014 March 16, 2016
NCT02298218 Completed Phase 4 Clinical Study About the Role of COX-2 Inhibitor in Liver Cirrhosis With Biliary Atresia September 2009 December 2011
NCT02706054 Completed Phase 3 Treatment of Recent Onset Low Back Pain With Periradicular Injections of Meloxicam May 2012 December 2015
NCT03896009 Completed Phase 3 Maximizing Outcomes in Treating Acute Migraine March 4, 2019 December 10, 2019
NCT04003350 Completed N/A The Effect of Prolonged Multimodal Analgesic Regimen on Post Hospital Discharge Opioid Use and Pain Control After Primary Total Knee Arthroplasty December 21, 2017 March 15, 2019
NCT04771741 Completed Opiate Free Multimodal Pain Pathway in Elective Foot and Ankle Surgery: A Prospective Study December 1, 2020 April 26, 2023
NCT01430559 Completed N/A Effect Of Meloxicam Versus Placebo In Mainland Chinese Patients With Osteoarthritis Of The Knee October 24, 2011 March 27, 2013
NCT02003625 Completed Phase 2 Meloxicam vs Placebo for Mobilization October 2013 April 2019
NCT02078102 Completed Phase 2 A Phase II Trial Using Meloxicam Plus Filgrastim in Patients With Multiple Myeloma and Non-Hodgkin's Lymphoma March 11, 2014 February 21, 2019
NCT02180516 Completed Safety and Efficacy of Meloxicam Compared to Other Nonsteroidal Antiinflammatory Drugs (NSAIDs) in an Observational Cohort Study of Patients With Rheumatoid Arthritis, Osteoarthritis, Lumbago, Scapulohumeral Periarthritis, Neck, Shoulder and Arm Syndrome October 2001
NCT02182739 Completed Observational Study of Meloxicam in Any Labeled Indication January 2001
NCT02183064 Completed Phase 3 Study to Compare Prescription Non-Steroidal Anti-Inflammatory Drug (NSAID) Changes, Health Care Utilization, Efficacy and Safety of Meloxicam 7.5 mg Versus Usual Care Administration of Prescription NSAIDs in a Managed Healthcare Setting in Patients With Osteoarthritis October 1998
NCT02183116 Completed Phase 4 A Study to Access the Efficacy and Safety of Meloxicam in Patients With Osteoarthritis of the Knee October 1998
NCT02183129 Completed Phase 4 Study to Assess the Efficacy and Safety of Meloxicam vs. Diclofenac SR in Patients With Osteoarthritis of the Knee April 1, 1999
NCT02184052 Completed Safety and Efficacy of Mobic® Ampoules in the Initiation of Treatment of Painful Exacerbations of Osteoarthritis, Rheumatoid Arthritis and Other Similar Painful Inflammatory Conditions July 2003
NCT05974501 Recruiting Phase 4 Pre vs Post Block in Total Knee Arthroplasty (TKA) September 29, 2023 July 1, 2024
NCT04766996 Terminated Phase 4 PROUD Study - Preventing Opioid Use Disorders May 17, 2021 December 27, 2021
NCT03473665 Terminated Phase 4 Non-Steroidal Anti-inflammatory Drugs in Axial Spondyloarthritis March 1, 2018 August 2, 2019
NCT04490434 Unknown status Phase 1 Drug-drug Interaction Between DWP14012 and Three Different Kinds of NSAIDs June 19, 2020 November 30, 2020
NCT01346137 Unknown status Phase 2 Study of a COX-2 Inhibitor for Prevention of Ovulation January 2011 September 2011
NCT04322175 Unknown status Phase 1 Pharmacokinetic and Tolerance Study of Meloxicam Eye Drops in Healthy Volunteers December 16, 2019 July 1, 2020
NCT04480359 Unknown status Phase 2/Phase 3 Bawei Shenqi Pill in the Treatment of Ankylosing Spondylitis October 1, 2017 September 30, 2020
NCT02448199 Unknown status Phase 3 Study of Association of Anti-inflammatory and Anti-rheumatic July 2015 July 2016
NCT03586934 Withdrawn Phase 3 Multimodal Analgesia in Shoulder Arthroplasty June 1, 2018 June 1, 2019